Neuroprotective agents in the management of glaucoma

Eye
Carlo NucciR Mancino

Abstract

Glaucoma is an optic neuropathy, specifically a neurodegenerative disease characterized by loss of retinal ganglion cells (RGCs) and their axons. The pathogenesis of RGC loss in glaucoma remains incompletely understood and a broad range of possible mechanisms have been implicated. Clinical evidence indicates that lowering intraocular pressure (IOP) does not prevent progression in all patients; therefore, risk factors other than those related to IOP are involved in the disease. The need for alternative, non-IOP-lowering treatments focused at preventing progression, that is, neuroprotectants, has become of interest to both the patient and the physician. Experimental evidence accumulated during the past two decades lend a great deal of support to molecules endowed with neuroprotective features. However, translation to the clinic of the latter drugs results unsuccessful mostly because of the lack of reliable in vivo measure of retinal damage, thus hampering the good therapeutic potential of neuroprotective agents given alone or as adjuvant therapy to IOP-lowering agents. Further research effort is needed to better understand the mechanisms involved in glaucoma and the means to translate into clinic neuroprotective drugs.

References

Aug 15, 1993·American Journal of Ophthalmology·N ChaturvediE B Dreyer
Nov 20, 2002·Neuroreport·Toshiyuki OshitariEmiko Adachi-Usami
Sep 1, 2005·Experimental Eye Research·Chang Hwan ParkGyeong Jae Cho
May 26, 2006·Investigative Ophthalmology & Visual Science·Khaled K Abu-AmeroThomas M Bosley
Aug 1, 2006·Experimental Eye Research·Frank SchuettaufPawel Grieb
Aug 7, 2007·International Review of Neurobiology·Carlo NucciLuigi A Morrone
Jun 4, 2008·Optometry and Vision Science : Official Publication of the American Academy of Optometry·William CheungM Francesca Cordeiro
Aug 14, 2008·The British Journal of Ophthalmology·N GuptaY H Yücel
Oct 22, 2008·Progress in Brain Research·Claudio CedroneCarlo Nucci
Oct 22, 2008·Progress in Brain Research·Li Guo, M Francesca Cordeiro
Oct 22, 2008·Progress in Brain Research·Vincenzo ParisiGianluca Manni
Oct 22, 2008·Progress in Brain Research·Rossella RussoLuigi Antonio Morrone
Jul 28, 2009·Gastroenterología y hepatología·Felipe de la Morena López, Javier P Gisbert
Dec 22, 2010·Indian Journal of Ophthalmology·Sushil K VasudevanJonathan G Crowston
Jan 25, 2011·American Journal of Ophthalmology·Theodore KrupinUNKNOWN Low-Pressure Glaucoma Study Group
Mar 26, 2011·Eye·M F CordeiroS E Moss
Jun 28, 2011·Investigative Ophthalmology & Visual Science·Caterina GaglianoAntonio Longo
Jan 10, 2012·Neurochemistry International·María Gutiérrez-FernándezExuperio Díez-Tejedor
Jun 14, 2012·Lancet·Antoni DávalosUNKNOWN International Citicoline Trial on acUte Stroke (ICTUS) trial investigators
Sep 18, 2012·Current Opinion in Pharmacology·Carlo NucciFrancesco G Garaci
Sep 27, 2012·Biochimica Et Biophysica Acta·Paolo Fagone, Suzanne Jackowski
Apr 26, 2013·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·L OttobelliL Rossetti
Aug 13, 2013·American Journal of Ophthalmology·Dorothea PetersAnders Heijl
Dec 18, 2013·Apoptosis : an International Journal on Programmed Cell Death·Dongwook LeeWon-Kyu Ju
Apr 17, 2014·International Journal of Molecular Sciences·Andrea MatteucciFiorella Malchiodi-Albedi
Apr 18, 2014·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Karsten Overgaard
May 16, 2014·Ophthalmology·Mehrdad MalihiArthur J Sit
Jun 3, 2014·Indian Journal of Ophthalmology·Gloria RobertiGianluca Manni
Jan 1, 2013·Brain Sciences·José Alvarez-Sabín, Gustavo C Román

❮ Previous
Next ❯

Citations

Feb 16, 2019·The Medical Journal of Australia·Jed Lusthaus, Ivan Goldberg
Jul 13, 2019·Developmental Neurobiology·George G BastakisMaria Savvaki
Oct 7, 2019·Journal of Neurochemistry·María F González FleitasRuth E Rosenstein
Jan 15, 2020·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yasuko YamamotoNaveed K Shams
Sep 7, 2019·The British Journal of Ophthalmology·Sohan Singh Hayreh
May 16, 2020·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yoshihiko EsakiNaveed K Shams
Dec 12, 2018·Neural Regeneration Research·Alessio Martucci, Carlo Nucci
Jul 25, 2019·Medicine·Xiu-Li Zhang, Li Qin
Sep 11, 2019·Investigative Ophthalmology & Visual Science·Shereif HaykalFrans W Cornelissen
Sep 26, 2019·Neural Regeneration Research·Alessio MartucciRaffaele Mancino
Nov 12, 2019·Frontiers in Neurology·Silvia MinosseNicola Toschi
Dec 12, 2020·Scientific Reports·Nevin W El-NimriSally L Baxter
Dec 3, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pier Franco Marino On Behalf Of Qualicos Study Group
Dec 31, 2020·Pharmaceutics·Ognjenka RahićEdina Vranić
Feb 6, 2021·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Syed S Ahmad
Sep 25, 2020·Journal of Clinical Medicine·María D Pinazo-DuránJavier Moreno-Montañés
Nov 7, 2020·Experimental Eye Research·Yuki IwataMasamitsu Shimazawa
Jun 3, 2021·International Journal of Molecular Sciences·Yue RuanAdrian Gericke
May 30, 2021·Translational Research : the Journal of Laboratory and Clinical Medicine·Mary Ann Stepp, A Sue Menko
Aug 8, 2021·International Journal of Molecular Sciences·Stefania VernazzaAnna Maria Bassi

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging technique
imaging techniques

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Indian Journal of Ophthalmology
Sushil K VasudevanJonathan G Crowston
Current Neuropharmacology
Luigi Antonio MorroneRossella Russo
Annual Review of Vision Science
Mohammadali Almasieh, Leonard A Levin
© 2022 Meta ULC. All rights reserved